Patents by Inventor Mordecai Popovtzer

Mordecai Popovtzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of cholecalciferol derivatives for the treatment of renal bone disease
    Patent number: 4997824
    Abstract: A method and composition for an improved treatment of human renal osteodystrophy, comprising the administration of 6-40 mcg/d (micrograms per day) of 24,25(OH).sub.2 D.sub.3 in combination with amounts of 1-alpha(OH)D.sub. 3 or 1,25(OH).sub.2 D.sub.3 or DHT.sub.2, which will maintain in the serum of patients the calcium concentration at 10-11 mg/dl (milligrams per deciliter) and the phosphate concentration at 5.5-6.0 mg/dl (milligrams per deciliter) and the numerical multiplication product of calcium x phosphate not more than 60-65.
    Type: Grant
    Filed: July 22, 1987
    Date of Patent: March 5, 1991
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Mordecai Popovtzer, Ben Z. Weiner, Shmuel Edelstein, Zeev Mazor, David Ladkani, Benjamin Shalita, John A. Kanis